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Abstract
We describe the design and characterization of a set of fusion proteins of the Escherichia coli lactose (lac) permease in which a set of five
different soluble ‘‘carrier’’ proteins (cytochromeb562, flavodoxin, T4 lysozyme, h-lactamase and 70 kDa heat shock ATPase domain) were
systematically inserted into selected loop positions of the transporter. The design goal was to increase the exposed hydrophilic surface area of
the permease, while minimizing the internal flexibility of the resulting fusion proteins in order to improve the crystallization properties of the
membrane protein. Fusion proteins with insertions into the central hydrophilic loop of the lac permease were active in transport lactose,
although only the fusion proteins with E. coli cytochromeb562, E. coli flavodoxin or T4 lysozyme were expressed at near wild-type lac
permease levels. Eight other loop positions were tested with these three carriers, leading to the identification of additional fusion proteins that
were active and well-expressed. By combining the results from the single carrier insertions, we have expressed functional ‘‘double fusion’’
proteins containing cytochromeb562 domains inserted in two different loop positions. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The central difficulty in the structural analysis of mem-
brane proteins by diffraction methods is the production of
well-ordered crystals. In order to understand how detergent-
solubilized membrane proteins form three-dimensional crys-
tals, it is essential to consider the properties of the funda-
mental particle that assembles into the crystalline array, the
protein–detergent complex (PDC). The PDC consists of
two distinct types of surfaces: a central micelle-like deter-
gent belt that protects the hydrophobic transmembranous
segments of the protein from the bulk aqueous solvent, and
two flanking extramembranous caps which have surface
properties that are similar to those of soluble proteins. Most
of the a-helical membrane proteins that have been crystal-
lized from detergent solutions contain large hydrophilic
domains, and in these cases, it is commonly observed that
most of the intermolecular contacts that make up the
crystalline lattice are due to polar interactions between these
surfaces (reviewed in Refs. [1,2]), although exceptions are
known [3,4]. The central detergent-coated belt region of the
PDC is generally considered to have a flexible and dynamic
surface since it is formed largely by the amphiphile head-
groups. Although detergent–detergent contacts may be
important in the crystal [3,5], these are not usually the
ordered, regular determinants of the lattice. Thus, membrane
proteins that have large extramembranous domains are
considered to be promising candidates for crystallization
because the lattice contacts between these extended polar
domains can result in the formation of large cavities that can
accommodate the detergent-coated domains.
We wish to broaden the scope membrane proteins that can
be studied by X-ray crystallography to include proteins that
do not inherently contain large polar domains. In particular,
proteins that consist of a series of transmembrane a-helices
linked only by relatively short polar loops, such as many of
the proteins involved in secondary transport [6], do not have
an architecture with high potential for crystal formation. We
have used the Escherichia coli lactose (lac) permease as a
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model system to develop methods to optimize the surfaces of
membrane proteins for crystallization studies.
The lac permease is a monomeric protein consisting of
12 transmembrane a-helices connected by short hydrophilic
loops, and catalyses the 1:1 coupled symport of protons and
h-galactosides (reviewed in Ref. [7]). A battery of techni-
ques that combine molecular biology with various biochem-
ical and biophysical approaches have culminated in a
packing model and a reaction mechanism [8], but the direct
visualization of the protein at the atomic level has resisted
all efforts to date. Because the permease lacks large extra-
membranous domains, we are pursuing a strategy to re-
engineer the surface features of this transporter. The design
goal is to create a PDC with a larger exposed polar surface
area relative to the parent protein with the aim of increasing
the potential for crystallization.
We have made a series of internal fusion proteins of the
lac permease with various ‘‘carrier’’ proteins in which the
carrier domain is inserted into the selected hydrophilic loops
between successive transmembrane helices of the permease.
A carrier is an unrelated soluble, monomeric protein whose
3D structure is available in the Protein Data Bank (PDB),
and whose N- and C-termini are close together in space at
the surface of the protein [9,10]. Our fusion strategy shares
some features of using complexes of membrane proteins
with antibody fragments for crystallization [11–16],
although in our case, the surface engineering is done at
the genetic level and thus allows for a wider diversity in the
resulting PDCs.
A key design feature of these fusion proteins is that the
carrier is introduced into a loop position of the target
membrane protein, and we have inserted a series of candi-
date carrier proteins into each of nine different hydrophilic
loops of the lac permease (Fig. 1). More traditional ‘‘head-
to-tail’’ C- or N-terminal fusion proteins rarely crystallize,
even when the two partners are soluble proteins, probably
because of the dynamic and flexible nature of the fusion. In
contrast, the internal fusion design generates particles that
are internally rigid by virtue of the two peptidic linkages
that connect the pair of domains. As a result, an internal
fusion protein is expected to have fewer internal degrees of
freedom then a head-to-tail fusion, and is thus more likely to
crystallize. A preliminary ‘‘proof-of-principle’’ study of an
internal fusion between two soluble proteins, the maltose
binding protein and cytochromeb562, has produced crystals
that diffract to 2.2 A˚ (CKE, V. Ahn and GGP, in preparation,
see also Ref. [17]). The use of head-to-tail fusions for the
crystallization of membrane proteins has also been
described [18,19]. A prototype of an internal carrier fusion
protein containing a cytochromeb562 insertion in the central
hydrophilic loop of the lac permease [9,10] (‘‘red perme-
ase’’) has produced well-ordered two-dimensional crystals
resulting in a projection map calculated at a resolution of 2
nm [20]. In this paper, we describe the construction and
characterization of an extended series of internal carrier
fusion proteins of the lac permease. The biochemical prop-
erties of three of these fusion proteins in detergent solutions
are investigated in the accompanying paper [21].
2. Materials and methods
2.1. Materials
[1-14C]-Lactose and the enhanced chemiluminescence
(ECL) detection kit were purchased from Amersham.
Horseradish peroxidase conjugated anti-mouse IgG was
obtained from Sigma, and Ni-NTA resin and Penta-His
antibody (mouse anti-(H)5) were from Quiagen. Deoxyoli-
gonucleotides were purchased from ACGT Corp. (Toronto,
Ontario). All site-directed mutagenesis was carried out with
the Quikchange protocol (Stratagene).
2.2. Insertion of carrier proteins into the central loop of the
permease
The template expression vector used in this study con-
sisted of a cassette version of the lac permease gene under the
control of a lac promoter (vector EMBL-X56095) with 10
additional histidine codons at the 5Vend of the gene. The
histidine-tagged protein with no carrier insert is referred to as
‘‘wild-type.’’ The construction of a lactose permease fusion
protein with an E. coli cytochromeb562 inserted into the
central hydrophilic loop (red permease, ‘‘L6_cyt_N2C6’’)
has been described [9,10]. In this plasmid, the cytochro-
meb562 insert had flanking 5Vand 3VXhoI restriction enzyme
sites. To construct the other L6 expression vectors described
in this paper, the 3VXhoI site from the L6_cyt_N2C6 gene
was replaced with a SacI site, and the DNA for the inserts
were amplified by PCR to introduce fragments with the
appropriate 5VXhoI and 3VSacI sites. Vector and PCR pro-
duces were digested with XhoI and SacI and ligated. All
constructs were confirmed by dideoxynucleotide sequenc-
ing over the full length of the fusion protein coding region.
Five codons corresponding to the C-terminal linker in
the L6_cyt_N2C6 vector were deleted to create the
L6_cyt_N2C1 construct. For the other the carrier domains
used in this study, the source of the template DNA for the
PCR reactions were as follows: (i) E. coli flavodoxin, Met1
to His171 [22], amplified from E. coli K12 genomic DNA;
(ii) bacteriophage T4 lysozyme, Met1 to Leu164 [23], am-
plified from a plasmid provided by B. Matthews (U Oregon);
(iii) murine adenosine deaminase, Ala6 to Gln352 [24],
amplified from I.M.A.G.E. consortium clone 577879; (iv)
the ATPase domain from the 70 kDa human heat shock
protein, Gly4 to Gly382 [25], amplified from I.M.A.G.E.
consortium clone 565948; (v) E. coli TEM1 h-lactamase,
His26 to Trp290 [26], amplified from plasmid pET32a DNA
(Novagen). The exact sequence boundaries for the carriers
were chosen from an inspection of the appropriate PDB entry
in order to identify the closest approach between the ordered
residues at each termini. The construction of the coding
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regions for these fusion proteins introduced single residue
linkers between the carrier and the lac permease, and are
referred to as the ‘‘N1C1’’ series of constructs. Since the exact
structure of the lactose permease central hydrophilic loop is
unknown, and since linkers that are too short could destabi-
lize the internal fusion proteins, a second set of fusion
proteins was constructed that contained longer five-residue
serine/glycine linkers at both the N- and C-terminal ends of
the carrier domains. These constructs are referred to as the
‘‘N5C5’’ series.
2.3. Carrier insertions into other permease loops
In order to insert carrier domains into loops other than the
central hydrophilic domain, the unique XhoI site in the
original 10-His lac permease cassette gene was replaced
with a SalI site, resulting in a substitution of serine 194 to a
threonine in the central hydrophilic loop. This vector was
then used to generate a series of vectors in which tandem
XhoI and SacI sites were introduced into 8 of the remaining
10 hydrophilic loops that connect successive transmembrane
helices. The mutagenesis resulted in the following amino
acid changes in the permease sequence: L1: 36-DISSIRSSD-
44 ; L2: 70-LGSSISSSLRK-73; L3: 101-YNSSVSSIV-109;
L5: 159-GISSTSSNQ-167; L7: 251-FASSEQSSRV-260;
L9: 309-ATSSLESSIL-318; L10: 337-ITSSFESSFS-346;
L11: 370-GNSSESSGF-378 (residue numbering based for
the wild-type sequence, with amino acid substitutions indi-
cated by singly underlined residues and insertions indicated
by double underlines). These vectors are referred to as the
parent Lx vectors, where x refers to the designated hydro-
philic domain. Inserts for the cytochromeb562 (N2C1 link-
ers), T4 lysozyme (N1C1 and N5C5 linkers) and flavodoxin
(N1C1 and N5C5 linkers) carriers were prepared by diges-
tion of the L6 constructs described in the section above with
both XhoI and SacI restriction enzymes, and ligated into the
Lx parent vectors prepared by reaction with the same two
enzymes. All constructs were verified by DNA sequencing.
2.4. Shortened central loop
Two constructs were made to test the effect of deleting
residues from the central hydrophilic domain of the perme-
ase. These were L6_cyt_D11, corresponding to a deletion
of permease residues Ala195-His205, and L6_cyt_D19,
corresponding to a deletion of residues Ala195-Ala213
(wild-type lac permease numbering).
2.5. Double fusion constructs
Lac permease ‘‘double fusion’’ proteins containing cyto-
chromeb562 inserts at positions L1 and L6, and L2 and L6
were constructed by introducing a fragment digested with
XhoI and HindIII from the L6_cyt_N2C1 vector into either
the L1_cyt_N2C1 or L2_cyt_N2C1 plasmid prepared by
digestion with SalI and HindIII. An L6/L10 double cyto-
chromeb562 fusion protein was made with a similar strategy
by combining EcoRI/AflII fragments of the L6_cyt_N2C1
and L10_cyt_N2C1 plasmids.
2.6. Lactose transport
E. coli T184 cells [27] were transformed with plasmids
containing lac permease constructs, grown to an A600 of 1.0
and induced with 0.2 mM IPTG for 2 h. Cells transformed
with a similar plasmid without the lac permease gene served
as a negative control, and did not display any measurable
transport. Cells were washed in 100 mM potassium phos-
phate pH 7.5, 10 mM MgSO4 and resuspended to an A420 of
10.0 in the same buffer. [1-14C]-Lactose was added to a
final concentration of 0.4 mM, and cells were collected by
rapid filtration at specified time points. Initial rates of
lactose uptake were measured at 1 min, and steady state
accumulation was measured at 60 min. The levels of
accumulated lactose was measured by liquid scintillation
counting of the filters [28]. All measurements were done in
triplicate.
2.7. Western blots
Protein expression levels were measured by Western blot
analysis of total membranes. Transformed E. coli T184 cells
(1.5 ml) at an A420 of 10.0 were collected by centrifugation
and resuspended in 0.5 ml lactose transport wash buffer. The
cells were lysed by sonication and cell debris was removed
by centrifugation. Membranes were pelleted by ultracentri-
fugation and directly taken up in 20 Al SDS-PAGE sample
buffer. After SDS gel electrophoresis, the proteins were
blotted on a nitrocellulose membrane. The blots were
developed using a mouse Anti-Penta-His primary antibody,
a peroxidase conjugated antimouse IgG secondary antibody,
and visualized by ECL.
3. Results
3.1. Characterization of internal L6 fusion proteins
The internal fusion proteins carrying cytochromeb562
(cyt), T4 lysozyme (lyso), flavodoxin (fla), h-lactamase
(TEM), adenosine deaminase (ADA) or the 70 kDa heat
shock protein ATPase domain (HSC) in the central hydro-
philic loop of lactose permease are described in Fig. 1. In the
cases of lysozyme, flavodoxin, ADA and h-lactamase, we
investigated two constructs for each insertion domain, one
with minimal length linkers at the N- and C-termini of the
inserted carrier domain, referred to as N1C1, and one with
extra amino acids at the two protein junctions (N5C5). These
were characterized for expression and lactose transport
activity (Fig. 2A,B). Western blot analysis showed strong
expression signals for wild-type lac permease, the cytochro-
meb562 fusion and the two lysozyme constructs, while the
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Fig. 1. (A) Schematic representation of the lac permease (adapted from Ref. [33]), with the insertion site of the carriers indicated by the thick arrowhead, and
the C-terminal positions of the two truncations in the central loop indicated by the small arrows. (B–G) Ca representations of the soluble proteins used as
carrier domains for insertion into the central loop of the lactose permease. The N- and C-termini of the proteins used in the fusion inserts are indicated. (B)
Cytochromeb562, (PDB ID: 256B; Ca3 to Ca106 distance: 11.1 A˚; cofactor: protoporphyrin IX with bound Fe
2 + ), (C) flavodoxin (PDB ID: 1AG9; Ca1 to
Ca171 distance: 14.9 A˚; cofactor: FMN), (D) T4 lysozyme (PDB ID: 2LZM; Ca1 to Ca164 distance: 11.4 A˚), (E) h-lactamase (PDB ID: 1FQG; Ca26 to
Ca290 distance: 7.6 A˚), (F) adenosine deaminase (PDB ID: 2ADA; Ca6 to Ca352 distance: 17.3 A˚; cofactor: Zn2 + ), (G) heat shock ATP hydrolase (PDB ID:
3HSC; Ca4 to Ca382 distance: 10.4 A˚; cofactor: Mg2 +ADP). (H) Amino acid sequences in the region of the junctions between the lac permease and the
carrier moieties in the L6 series of constructs. The lac permease residues that flank the inserts are serine 193 and serine 194 at the N- and C-terminus,
respectively (wild-type lac permease numbering).
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flavodoxin fusion proteins have a slightly reduced expres-
sion level, and only weak or no expression could be detected
for the ADA and HSC fusion proteins. Expression levels
were also very low for the h-lactamase fusions (data not
shown). As is commonly observed with very hydrophobic
membrane proteins, the SDS complexes migrated at anom-
alously high rates in the gel, giving smaller than expected
apparent molecular weights. Surprisingly, the rates of migra-
tion of the fusion proteins correlated only roughly with the
size of the inserted carrier domains. The initial rate of lactose
transport in the L6_cyt_N2C1 and L6_lyso_N1C1 pro-
teins was comparable to that of wild-type permease, while
Fig. 2. (A) Expression levels of the L6 fusion proteins as analyzed by Western blotting of total membranes. (B) Lactose transport activity of the L6 fusions. The
initial rate and steady state level of accumulation are indicated by black bars and hatched bars, respectively. The rates were normalized to the transport activity
of wild-type lac permease. (C) Expression levels of the cytochromeb562 insertions into each of nine hydrophilic loops of the lac permease as analyzed by
Western blotting of total membranes. (D) Transport activity of the lac permease-cytochromeb562 fusion proteins. The initial rate and steady state level of
accumulation are indicated by black bars and hatched bars, respectively. The rates were normalized to the transport activity of wild-type lac permease.
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the N5C5 lysozyme and both flavodoxin fusion proteins
exhibited slightly reduced initial rates of transport. Most of
these constructs reached a steady state level of lactose
accumulation that was comparable to wild-type lac perme-
ase. The ADA, HSC and h-lactamase fusion proteins had a
lower, but significant level of activity, suggesting that func-
tional protein was produced, but at levels below the threshold
of detection in the Western blots used here.
3.2. Insertions into other loops
Insertions of carrier proteins into loops other than the
central hydrophilic domain were less well tolerated, as
shown by the series containing the cyt_N2C1 insertions
(Fig. 2C,D). In these cases, the L1, L2 and L10 fusion
proteins were expressed at roughly wild-type levels, but
these had significantly reduced initial rates of transport. The
expression and activity data for the entire series of the nine
Lx parent clones (containing no inserted domains), and 45
permease/carrier fusion proteins are summarized in Fig. 3.
The L6 position was clearly the most tolerant of the fusion
sites, followed by the L2, L10 and L1 sites in decreasing
order of suitability. Insertion into any of the five remaining
sites (L3, L5, L7, L9, L11) resulted in the loss of essentially
all useable expression and activity. The L3 series was the
most poorly behaved of this set, as neither the parent
construct, nor any of the insertion fusions, produced viable
protein. The length of the linkers was not an important
factor, as can be seen by a comparison of the N1C1 and
N5C5 series in the lysozyme or flavodoxin fusion proteins.
Consistent with the L6 results, the cytochromeb562 and
lysozyme fusion proteins were better behaved than the
flavodoxin fusion proteins across most of the insertion sites.
The cell paste from bacteria producing the well-expressed
L1, L2, L6 and L10 cytochromeb562 fusion proteins was
visibly red. In addition, the purified cytochromeb562 fusion
proteins had similar UV/visible spectra, with an A280/A426
ratio of approximately 1, indicating full occupancy of heme
in the cytochromeb562 domain of the fusion proteins [9].
Fig. 3. Summary of the expression and activity of the fusions with five
different carriers inserted into each of nine different loops of the permease.
Larger circles represent higher levels of expression, and darker shading
indicates higher levels of transport activity.
Fig. 4. Expression and transport activity for cytochromeb562 fusion proteins with deletions in the central hydrophilic loop. (A) Transport activity as measured by
lactose uptake in intact cells. (B) Expression levels of the L6 deletion mutants as analyzed by Western blotting of total membranes.
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Thus, the cytochromeb562 moiety of these fusion proteins is
able to bind heme when it is localized to either the
cytoplasmic or periplasmic side of the membrane.
3.3. Shortened central permease loop
For a given carrier, similar levels of expression and
activity were observed in the N1C1 and N5C5 series of
fusion proteins (Figs. 2 and 3), suggesting that in these
cases, the linkers were not interfering with the folding of
either of the protein domain. Because our goal was to
reduce the flexibility between the protein pairs by minimiz-
ing the length of the linker peptides, we investigated the
effect of shortening the lac permease central hydrophilic
loop in the L6 cytochromeb562 fusion proteins (Fig. 4). The
initial rate of transport was higher for the N2C1 and D11
proteins than for the wild-type and N2C6 proteins. How-
ever, the L6_cyt_D19 fusion protein had markedly reduced
transport activity even though it was well expressed, sug-
gesting that this degree of shortening was not fully compat-
ible with the structural requirements of the permease across
the transport cycle, or resulted in a folding defect in the
permease.
3.4. Double cytochromeb562 fusion proteins
The L1/L6, L2/L6 and L6/L10 double cytochromeb562
fusions were well-expressed, and had activities similar to
those of the L1, L2 and L10 single cytochromeb562 proteins,
respectively (data not shown). Thus, the L1, L2 and L10
insertions are compatible with the presence of the well-
tolerated L6 insertion, and in these cases, the effects on the
fusion protein are essentially additive. In these double
fusions, the ratio of the absorbances at 426 and 280 nm
in purified protein preparations is roughly twice that of the
single cytochromeb562 fusion proteins, indicating that both
of the cytochromeb562 carrier domains contain bound
heme.
4. Discussion
It was not expected that all of the designed fusion
proteins would produce material suitable for crystallization
trials, and the modular system was designed as a system to
readily generate a large number of fusion proteins that
could be screened to identify a subset of proteins suitable
for further study. The majority of the L6 fusion proteins
were active in lactose transport, and half of these could be
expressed at levels comparable to the wild-type protein. In
addition to the increase in polar surface area, features such
as purification tags or color (in the case of the cytochro-
meb562 and flavodoxin fusion proteins) can be introduced
by this strategy. A 100-residue biotinylation domain from
the oxaloacetate decarboxylase of Klebsiella pneumoniae
has previously been inserted into this position of the
permease, and the resulting protein was active and well-
expressed [29]. Fusion proteins containing larger inserts
(h-lactamase, ADA, HSC) showed significant lactose
transport activity, but were expressed only at lower levels
and thus were not suitable for purification and further
characterization. The products of these larger constructs
were roughly over 700 amino acids, and recombinant ex-
pression of proteins of this size in E. coli is often pro-
blematic, even with soluble proteins. For insertions into
other loop positions, the rate of success was significantly
lower, and only the cytochromeb562 and lysozyme inserts
into the L1, L2, L6 and L10 positions are being pursued in
crystallization trials.
The lac permease and many other proteins in its class can
readily tolerate mutations and breaks in the loops structures
[7,30]. In a pioneering study, McKenna et al. [31] consid-
ered the effect of inserting histidine residues into the hydro-
philic domains of the lac permease, and found that either
two or six histidine insertions into the L2, L8 and L9
positions had serious negative effects on the protein, while
all other sites were well tolerated. A ‘‘split lac permease’’
with a break in the backbone chain at the L2 site was
functional [32], and we find here that the fusion inserts at
this position also result in functional protein, indicating that
the effect on the transport activity depends on the exact
nature of the loop modifications. In general, the insertion of
the carrier proteins presented here have more deleterious
effect on the lac permease than the large number of
insertions, deletions or interruptions in the backbone struc-
ture that have been described for this protein [7]. The low
levels of expression in these fusion proteins could be the
result of problems at the level of expression, insertion and/or
short lifetime in the membrane.
In the internal fusion design, the optimal linker length that
allows for the proper folding of the protein partners depends
on the distance between the ordered terminal residues of the
carrier. The selected carriers introduce a gap of approximately
10 A˚ between the Ca positions and the permease loops (Fig.
1), and molecular modeling indicates that these distances can
be easily accommodated by N and C linkers of only a few
amino acids each. Because of the additional flexibility of
interface residues formally designated as belonging to ‘‘car-
rier’’ or ‘‘permease,’’ carrier inserts whose termini are within
this range are easily accommodated with very short linkers.
The properties of proteins with long (N2C6 or N5C5) or short
(N2C1 or N1C1) linkers were similar in all cases tested,
suggesting that the poor expression of the L6 ADA, HSC or
TEM fusion proteins, or of the L1, L3, L5, L7, L9 or L11
lysozyme or flavodoxin proteins were not due to internal
structural strain resulting from the insertion of the carrier.
Further support that the linkages between the permease and
the carriers are suitably relaxed in the L6 series is provided by
the observation that eleven residues from the permease
central polar loop could be removed from the cytochromeb562
fusion without affecting the transport activity of the protein
(Fig. 4). Weinglass and Kaback [33] describe similar dele-
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tions made in this loop of the wild-type lac permease. They
removed five amino acids without any effect on expression or
activity, while a deletion of 12 loop residues showed
increased rates of protein turnover and decreased transport
activity, and a 20-residue deletion resulted in trace levels of
insertion and activity. In our case, larger loop deletions
were well tolerated by the protein, presumably because of
the additional contribution of the inserted cytochromeb562
to the overall distance between the two transmembrane
helices.
The optimization of the length of the two linkers that
connect the protein domains is clearly an important issue for
the strategy of using internal fusion proteins for crystalliza-
tion. In principle, short, rigid linkers are favored for crys-
tallization, but a limited amount of flexibility may be
nonetheless tolerated, since it would allow the two protein
domains to sample a wider range of conformations. T4
lysozyme, for example, is well-known as a protein that is
readily crystallized, and yet exhibits a large hinge-bending
between the amino and carboxy-terminal domains [34] and
Ay et al. [17] have demonstrated variability of a hinge angle
in the crystal structure of an internal fusion protein between
two soluble domains.
There have been several examples of stabilizing ‘‘diffi-
cult’’ proteins via the formation of complexes with antibody
fragments for the purposes of crystallization with both
soluble and integral membrane proteins [11–16,35–37].
In the cases of the bacterial cytochrome c oxidase [11–
13] and the yeast cytochrome bc1 complex [15], the com-
plex with a cognate Fv fragment had several advantages: it
allowed the rapid purification of the PDC–Fv complex, the
Fv stabilized the structure by recognizing a conformational
epitope, and most significantly, the Fv was an important
contributor to the protein–protein contacts in the crystal
lattice. Note that antibody fragments that bind selectively to
a particular conformation state of the target protein may
reduce the aggregation problem and improve the crystalliz-
ability of the protein by restricting the internal dynamics of
the system [1]. Although the antibody fragment approach is
a powerful method for the study of membrane proteins, a
major limitation is the availability and production of suitable
monoclonal antibodies and their fragments specific for each
target protein. The carrier fusion approach circumvents this
problem, and can be used in conjunction with antibody
fragment methods.
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